Drugs / KK8123
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06525636 | Oct 2024 → Feb 2028 expected | X-linked hypophosphatemic rickets | Kyowa Kirin, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KK8123 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06525636 ↗ |
| Route | Subcutaneous | “Subcutaneous administration” NCT06525636 ↗ |